Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Thorac Oncol. 2016 Apr 24;11(8):1345–1356. doi: 10.1016/j.jtho.2016.04.013

Table 1.

Summary of PI3K subunit gene mutations identified in TET cell lines and primary tumors

Sample ID Sample Type WHO Histotype Mutation Gene Symbol PI3K Subunit Effect SIFT/PolyPhen Sanger Seq
MP57 Cell line & Tumor Thymic Carcinoma chr19:18273784G>C c.1117G>C p.G373R PIK3R2 p85β, Regulatory Missense Mutation deleterious/probably damaging Homozygous
IU-TAB1 Cell line Thymoma Type AB chr3:178936091G>A c.1633G>A p.E545K PIK3CA p110α, Catalytic Missense Mutation deleterious/probably damaging Heterozygous
N-Thy015 Tumor Thymic Carcinoma chr7:106508065G>A c.3309G>A p.R20H PIK3CG p110γ, Catalytic Missense Mutation deleterious/probably damaging Confirmed
Padua001 Tumor Thymic Carcinoma chr3:130427227C>G c.579C>G p.S173T PIK3R4 p150, Regulatory Missense Mutation benign/tolerated Confirmed
Padua026 Tumor Thymic Carcinoma chr3:178936091G>A c.1068G>A p.E545K PIK3CA p110α, Catalytic Missense Mutation deleterious/probably damaging Confirmed